新型冠状病毒肺炎诊疗方案(试行第八版 修订版)

2021-04-14 中华人民共和国国家卫生健康委员会 卫健委

各省、自治区、直辖市及新疆生产建设兵团卫生健康委、中医药管理局:

中文标题:

新型冠状病毒肺炎诊疗方案(试行第八版 修订版)

发布日期:

2021-04-14

简要介绍:

各省、自治区、直辖市及新疆生产建设兵团卫生健康委、中医药管理局:
  当前,世界各国正广泛开展新型冠状病毒疫苗预防接种,多数人员在接种疫苗后会产生新型冠状病毒特异性抗体。为进一步提高新型冠状病毒肺炎诊疗工作的科学性、规范性和有效性,我们组织专家对《新型冠状病毒肺炎诊疗方案(试行第八版)》相关内容进行修订,形成了《新型冠状病毒肺炎诊疗方案(试行第八版 修订版)》。现印发给你们,请参照执行。  

国家卫生健康委办公厅   国家中医药管理局办公室

2021年4月14日

相关资料下载:
[AttachmentFileName(sort=1, fileName=新型冠状病毒肺炎诊疗方案(试行第八版 修订版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=05bf61c00208282a, title=新型冠状病毒肺炎诊疗方案(试行第八版 修订版), enTitle=, guiderFrom=卫健委, authorId=0, author=, summary=各省、自治区、直辖市及新疆生产建设兵团卫生健康委、中医药管理局:, cover=, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Apr 14 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p style="color: #484848;">各省、自治区、直辖市及新疆生产建设兵团卫生健康委、中医药管理局:<br />  当前,世界各国正广泛开展新型冠状病毒疫苗预防接种,多数人员在接种疫苗后会产生新型冠状病毒特异性抗体。为进一步提高新型冠状病毒肺炎诊疗工作的科学性、规范性和有效性,我们组织专家对《新型冠状病毒肺炎诊疗方案(试行第八版)》相关内容进行修订,形成了《新型冠状病毒肺炎诊疗方案(试行第八版&ensp;修订版)》。现印发给你们,请参照执行。&ensp;&ensp;</p> <p style="color: #484848;">国家卫生健康委办公厅 &ensp;&ensp;国家中医药管理局办公室</p> <p style="color: #484848;">2021年4月14日</p>, tagList=[TagDto(tagId=99273, tagName=新冠肺炎)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=35, categoryName=预防与公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10475, appHits=321, showAppHits=0, pcHits=1170, showPcHits=10153, likes=2, shares=51, comments=23, approvalStatus=1, publishedTime=Fri Apr 16 07:23:13 CST 2021, publishedTimeString=2021-04-14, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Fri Apr 16 07:23:06 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 18:41:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=新型冠状病毒肺炎诊疗方案(试行第八版 修订版).pdf)])
新型冠状病毒肺炎诊疗方案(试行第八版 修订版).pdf
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1005306, encodeId=f298100530652, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Thu Aug 05 10:24:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974010, encodeId=09219e4010a7, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5185436933, createdName=ms8000001709311190, createdTime=Wed Jun 16 09:29:09 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961100, encodeId=53e8961100a0, content=比上一版更详细了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Wed Apr 28 05:54:14 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960955, encodeId=22c5960955d2, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:19:01 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959649, encodeId=b620959649ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d25484122, createdName=ms2000001941864021, createdTime=Fri Apr 23 06:36:00 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-08-05 Mr.d

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1005306, encodeId=f298100530652, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Thu Aug 05 10:24:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974010, encodeId=09219e4010a7, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5185436933, createdName=ms8000001709311190, createdTime=Wed Jun 16 09:29:09 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961100, encodeId=53e8961100a0, content=比上一版更详细了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Wed Apr 28 05:54:14 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960955, encodeId=22c5960955d2, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:19:01 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959649, encodeId=b620959649ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d25484122, createdName=ms2000001941864021, createdTime=Fri Apr 23 06:36:00 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-06-16 ms8000001709311190

    很好,学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1005306, encodeId=f298100530652, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Thu Aug 05 10:24:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974010, encodeId=09219e4010a7, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5185436933, createdName=ms8000001709311190, createdTime=Wed Jun 16 09:29:09 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961100, encodeId=53e8961100a0, content=比上一版更详细了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Wed Apr 28 05:54:14 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960955, encodeId=22c5960955d2, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:19:01 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959649, encodeId=b620959649ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d25484122, createdName=ms2000001941864021, createdTime=Fri Apr 23 06:36:00 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-28 我是谁是我

    比上一版更详细了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1005306, encodeId=f298100530652, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Thu Aug 05 10:24:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974010, encodeId=09219e4010a7, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5185436933, createdName=ms8000001709311190, createdTime=Wed Jun 16 09:29:09 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961100, encodeId=53e8961100a0, content=比上一版更详细了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Wed Apr 28 05:54:14 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960955, encodeId=22c5960955d2, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:19:01 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959649, encodeId=b620959649ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d25484122, createdName=ms2000001941864021, createdTime=Fri Apr 23 06:36:00 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-27 gujun830412

    看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1005306, encodeId=f298100530652, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Thu Aug 05 10:24:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974010, encodeId=09219e4010a7, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5185436933, createdName=ms8000001709311190, createdTime=Wed Jun 16 09:29:09 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961100, encodeId=53e8961100a0, content=比上一版更详细了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73835475130, createdName=我是谁是我, createdTime=Wed Apr 28 05:54:14 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960955, encodeId=22c5960955d2, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:19:01 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959649, encodeId=b620959649ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d25484122, createdName=ms2000001941864021, createdTime=Fri Apr 23 06:36:00 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-23 ms2000001941864021

    学习

    0